Clinical Trial Update: Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer (NSCLC) Stages IIIB/IV [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial of a vaccine therapy for non-small cell lung cancer (stage IIIB/IV) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Vaccine therapy

Snippet

Sponsor: Bioven Sdn. Bhd. | Conditions: Non-small-cell Lung Cancer (NSCLC) Stage IIIb/IV | Phase 2, Phase 3 | Status: TERMINATED